BioGaia AB – Year-end report 2020
Fourth quarter 2020 · Net sales totalled SEK 187.6 million (207.6), a decrease of 10% (excluding foreign exchange effects, -4%). · Product sales, net sales excluding royalty revenues, amounted to SEK 180.7 million (198.3), a decrease of 9% (excluding foreign exchange effects, -3%). · Net sales in the Paediatrics segment reached SEK 139.6 million (157.4), a decrease of 11%. · Net sales in the Adult Health segment amounted to SEK 47.3 million (49.9), a decrease of 5%. · Operating expenses amounted to SEK 94.7 million (86.1), an increase of 10%. · Operating profit